Ascertainment Bias in TB Treatment Trials: Can Systematic Assessment of Objective Endpoints Solve It?Carole D Mitnick, Andrew J Nunn
No abstract text is available yet for this article.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
You can now claim free CME credits for this literature searchClaim now